<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>1509922</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Castro Iglesias, A M</dc:author>
<dc:author>Figueiredo, L</dc:author>
<dc:author>Nogueira March, J L</dc:author>
<dc:author>Benavente, J</dc:author>
<dc:author>Barros, J M</dc:author>
<dc:author>Rodríguez Iglesias, B</dc:author>
<dc:author>Eceolaza, J</dc:author>
<dc:author>Ojea Calvo, A</dc:author>
<dc:description xml:lang="en">Contribution of our experience with Alpha-2a Interferon and Vinblastine, for the treatment of advanced renal cancer in patients formerly not treated with nephrectomy. Pathoanatomical diagnosis was confirmed by puncture biopsy. None of the 4 patients recruited in the protocol showed objective response. In 2 patients no change was observed and in the other 2 the disease progressed. In surviving patients it was impossible to sustain therapy for more than three months. Treatment was discontinued as a result of the Interferon side-effects, such as fever, myalgia, asthenia and neuritis.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>1992 Jun </dc:date>
<dc:title xml:lang="es">Resultados del tratamiento con interferón y vinblastina en el cáncer de riñón.</dc:title>
<dc:title xml:lang="en">[Results of treatment with interferon and vinblastine in renal cancer].</dc:title>
<dc:publisher>Actas urologicas espanolas</dc:publisher>
</metadata>
</record>
</pubmed-document>
